Navigation Links
Stallergenes Moves to the Cloud With Veeva CRM
Date:10/11/2011

BARCELONA, Spain, October 11, 2011 /PRNewswire/ --

Leading Specialty Pharmaceutical Company Consolidates Four On-Premise CRM Systems into One

Stallergenes, the world leader in sublingual immunotherapy, has selected Veeva CRM to replace its existing conventional on-premise systems to support its worldwide sales force. Veeva CRM is today's #1 selling cloud-based CRM solution for the global pharmaceutical and biotech industry.

Previously, Stallergenes utilised four different Customer Relationship Management (CRM) systems across 14 countries before selecting Veeva CRM.  Veeva was chosen from a pool of CRM vendors to support Stallergenes growing international operations and new sales force effectiveness initiative. According to the company, Veeva CRM proved to be the most innovative and robust solution, enabling improved customer targeting, increased understanding of customer behaviour and enhanced coordination of data between the field force, medical affairs and marketing teams.


"We needed a system that could support rapid growth across borders," said Cyril Tavier, vice president, international operations at Stallergenes. "Veeva's cloud-based solution is the gold standard in new, innovative technologies, allowing the high level of flexibility and scalability we need to support our expanding operations globally. Veeva is a perfect match for our company, and supports our mission as an industry innovator."

Thierry Grehaigne, vice president, information technologies at Stallergenes added, "We wanted a single, comprehensive CRM solution that would be intuitive and easy to use for all users across regions and that could keep pace with changing technology. Veeva had it all."

Stallergenes will also be rolling out Veeva's leading iPad application, iRep, to users in major European markets. Veeva iRep is the first integrated CLM/CRM application designed specifically for the Apple iPad. Veeva redesigned its CRM application to
'/>"/>

SOURCE Veeva Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber
2. STALLERGENES: Oralair(R) Grasses Obtains a Pediatric MA(1) in Germany
3. Stallergenes S.A.: Positive Results From a Phase IIb/III Clinical Trial on the House Dust Mite Desensitization Tablet
4. Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study
5. STALLERGENES: Persistent Efficacy Demonstrated After a Year on Actair(R) Followed by a Second Treatment-Free Year
6. STALLERGENES: Excellent 1st Half-Year 2010 Performance
7. Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
8. Trellis(R) Catheter Removes Blood Clots Quickly, Restoring Blood Flow in 771 Deep Vein Thrombosis (DVT) Patients
9. Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market
10. Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials
11. Debiopharm Moves Towards a New 6-Month Formulation of Decapeptyl(R) to Further Help Prostate Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2015)... , Aug. 3, 2015  Lexicon Pharmaceuticals, Inc. ... pivotal TELESTAR Phase 3 clinical trial met its ... etiprate in treating cancer patients with carcinoid syndrome ... standard of care. Telotristat etiprate was discovered using ... and is the company,s first discovery to complete ...
(Date:7/31/2015)... , July 31, 2015  Seeger Weiss LLP is ... (FDA) issued a warning letter to C.R. Bard, the manufacturer ... taking adequate strides to correct violations the agency found at ... these violations after the FDA cited them during Inspectional Observations ... in Bard,s Tempe, AZ , location and ...
(Date:7/31/2015)... July 31, 2015 RnRMarketResearch.com ... market research report that provides an overview of ... data sourced from in-house databases, secondary and primary ... needles market products pipeline spread across 124 pages, ... 73 tables and 5 figures is now available ...
Breaking Medicine Technology:Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 2Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 3Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 4Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 5Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 6Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 2Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 3Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 5
(Date:8/3/2015)... , ... August 03, 2015 , ... ... brokerage firm, announced today that Joe Williams has joined its growing California employee ... delivering HUB's differentiated service model to his clients. Mr. Williams will be joining ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... management and investigative services, has introduced a new logo and comprehensive brand ... that improve business outcomes for its customers. EMSI’s new tagline, “Powerful Information. ...
(Date:8/2/2015)... ... 03, 2015 , ... Career Step, an online institution offering ... for Healthcare Documentation Integrity’s (AHDI) conference being held in Alexandria, Virginia, on Friday ... AHDI conference provides us to interact with those in the healthcare documentation industry,” ...
(Date:8/2/2015)... (PRWEB) , ... August 02, 2015 , ... Molecular biologists ... powerful prognostic indicator for mesothelioma. Surviving Mesothelioma has just posted an article on the ... University of New South Wales tested for Ki67 expression in tissue samples from 42 ...
(Date:8/1/2015)... ... 2015 , ... Have you ever wondered what “Karma” really means? Does it even exist? Can ... , Vedic tradition, which gave birth to Hinduism, is one of the most ancient spiritual ... this tradition. According to the wisdom of this heritage, Karma is a very real and ...
Breaking Medicine News(10 mins):Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2Health News:Career Step to Exhibit at AHDI Conference in Alexandria, Virginia on August 7-8 2Health News:Scientists Link Protein Marker with Mesothelioma Prognosis in New Study, According to Surviving Mesothelioma 2Health News:Nithyananda Yoga Foundation to Conduct Global Webinar on Karma at No Charge on August 1st 2
... ... with Alzheimer,s disease and disabilities, and a decreasing work force to care for them, threatens ... care business owner. , ... NE (PRWEB) September 29, 2009 -- A crisis in aging, fueled by increasing numbers of ...
... ... foot and ankle Pain." Claims Dr. Katz , ... Tampa, FL (PRWEB) September 29, 2009 -- Foot pain and foot ... of solutions for their foot and ankle pain and are growing frustrated with continuous visits ...
... study by researchers at The George Institute for International Health ... to PCPs with acute lower back pain to have previously ... documented was vertebral fracture, with half of the cases identified ... in the October issue of Arthritis & Rheumatism , ...
... shoe choices early in life suffer with foot pain in later ... foot pain as women, due to type of shoes they wear. ... Arthritis Care & Research , a journal published by Wiley-Blackwell ... reveal that foot and toe symptoms are among the top 20 ...
... cancer with the Prostate Specific Antigen (PSA) test in ... becomes symptomatic, knowing whether screening is beneficial for these ... or no reductions in prostate cancer mortality among those ... against the more common and immediate downsides of increasing ...
... at Harbor-UCLA Medical Center (LA BioMed) will honor Los Angeles ... founder and president of Kakkis EveryLife Foundation, as its "Spirit ... 6 at the Terranea Resort in Rancho Palos Verdes. ... for the excellence each represents in his chosen field," said ...
Cached Medicine News:Health News:Crisis in Aging: Disability and Alzheimer's: Lack of Caregivers Threatens South Florida Seniors' Ability to Stay Home 2Health News:Crisis in Aging: Disability and Alzheimer's: Lack of Caregivers Threatens South Florida Seniors' Ability to Stay Home 3Health News:Crisis in Aging: Disability and Alzheimer's: Lack of Caregivers Threatens South Florida Seniors' Ability to Stay Home 4Health News:Dr. Marc Katz, Leading Podiatric Surgeon Adds High Powered Color Ultrasound To Cryosurgery Procedures and Treatments 2Health News:PCPs are front line defense in diagnosing serious illness in patients with acute lower back pain 2Health News:Women who make poor shoe choices at risk for foot pain later in life 2Health News:UNC expert: Better decision support tools needed for prostate cancer screening choice 2Health News:LA BioMed to honor Emil D. Kakkis, M.D., Ph.D., and LA County Supervisor Don Knabe 2
... Sterile E*Kits® can be a valuable ... care; when the items necessary for a ... facility protocols and continuum of care are ... are packaged in sequence of use, allowing ...
... to dry trays to specialty vaginal & ... Health offers the widest offering in patient ... that are proven to be safe and ... surgical site infections. Cardinal Health Scrub Care ...
The applicator is designed for a smooth delivery of the solution for surgical procedures....
... The Anti-HTLV Mixed Titer Performance Panel ... from weak to strong positive for antibodies ... is intended for use by manufacturers and ... assays. Comprehensive data from all major test ...
Medicine Products: